V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20212774 | 20154673 | 1.73 | 69.8 | null | 2017-08-14 | 2017-08-31 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101057982 |
| 20212775 | 20154674 | 1.62 | 60 | Palliative (P) | 2019-10-22 | 2019-11-15 | GEMCITABINE + NAB PACLITAXEL | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101335856 |
| 20212780 | 20154675 | 1.56 | 67.4 | Palliative (P) | 2019-02-05 | 2019-02-26 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 101617063 |
| 20212781 | 20154676 | 0 | 97 | Adjuvant (A) | 2018-03-14 | 2018-04-09 | GEMCITABINE + Paclitaxel Albumin | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100581247 |
| 20212783 | 20154677 | 1.52 | 50.5 | Palliative (P) | 2017-10-14 | 2018-08-31 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100183131 |
| 20212784 | 20154678 | 1.72 | 87 | null | 2017-09-02 | 2017-09-07 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100374257 |
| 20212785 | 20154679 | 1.63 | 77 | Palliative (P) | 2020-12-25 | 2021-01-21 | GEMCITABINE + NAB PACLITAXEL | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 101274463 |
| 20212789 | 20154680 | 1.73 | 58.5 | Curative (C) | 2020-10-28 | 2020-11-12 | Capecitabine (14 days)+Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 101664547 |
| 20212790 | 20154681 | 1.56 | 48 | Palliative (P) | 2021-05-31 | 2021-10-06 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | y | GEMCITABINE + NAB-PACLITAXEL | 100628859 |
| 20212794 | 20154682 | 1.65 | 80.45 | Palliative (P) | 2018-06-22 | 2018-08-17 | ECX | 02 | Y | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101807942 |
| 20212797 | 20154683 | 1.52 | 75.4 | null | 2018-09-20 | 2018-09-20 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 100955240 |
| 20212799 | 20154684 | 1.48 | 56.2 | Curative (C) | 2018-11-25 | 2018-12-04 | Cape+Cisplatin+Trastuzumab Main | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100062283 |
| 20212802 | 20154685 | 1.64 | 61 | Palliative (P) | 2017-12-30 | 2017-12-31 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101665287 |
| 20212803 | 20154686 | 1.65 | 79.1 | Palliative (P) | 2018-03-07 | 2018-03-24 | Capecitabine + Carboplatin + RT | 02 | N | CAPECITABINE + CARBOPLATIN | 101447717 |
| 20212806 | 20154687 | 1.64 | 74.9 | Palliative (P) | 2019-04-25 | 2019-05-08 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100833689 |
| 20212808 | 20154688 | 1.65 | 64.1 | Palliative (P) | 2018-05-28 | 2018-06-21 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101017301 |
| 20212809 | 20154689 | 1.81 | 93.8 | Palliative (P) | 2017-12-18 | 2017-12-18 | HCX (Cape + Cisp + Tras) - Main | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100280273 |
| 20212811 | 20154690 | 1.64 | 56 | Neo-adjuvant (N) | 2019-07-02 | 2019-07-17 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 101452593 |
| 20212816 | 20154691 | 1.52 | 71.4 | 03 | 2020-11-16 | 2020-11-24 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100469966 |
| 20212826 | 20154692 | 1.58 | 66.4 | Palliative (P) | 2018-08-25 | 2019-09-21 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100243583 |
| 20212828 | 20154693 | 1.85 | 80.1 | Palliative (P) | 2022-03-27 | 2022-04-07 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100803071 |
| 20212830 | 20154694 | 1.73 | 50.8 | null | 2020-03-08 | 2020-03-14 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | null | CAPECITABINE + CARBOPLATIN | 100300272 |
| 20212834 | 20154695 | 1.71 | 99.1 | Curative (C) | 2016-12-11 | 2016-12-11 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100215895 |
| 20212835 | 20154696 | 0 | 57.2 | Palliative (P) | 2016-05-29 | 2016-06-20 | GEMCITABINE + NAB PACLITAXEL | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100402343 |
| 20212839 | 20154697 | 1.61 | 64.8 | Palliative (P) | 2016-04-21 | 2016-09-18 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | CAPECITABINE + CARBOPLATIN | 100409557 |
| 20212841 | 20154698 | 1.77 | 100 | Palliative (P) | 2019-01-26 | 2019-01-28 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101741467 |
| 20212842 | 20154699 | 1.68 | 86.1 | null | 2019-05-28 | 2019-07-05 | GEMCITABINE + NAB PACLITAXEL | 02 | null | GEMCITABINE + NAB-PACLITAXEL | 100237198 |
| 20212843 | 20154700 | 1.61 | 64.4 | Adjuvant (A) | 2020-09-05 | 2021-02-24 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100275752 |
| 20212844 | 20154701 | 1.68 | 61.6 | Palliative (P) | 2018-04-30 | 2018-06-02 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100423380 |
| 20212849 | 20154702 | 1.68 | 85.2 | Palliative (P) | 2019-11-18 | 2019-12-06 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100859830 |
| 20212859 | 20154703 | 1.83 | 71 | Adjuvant (A) | 2016-10-23 | 2017-04-08 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101015457 |
| 20212861 | 20154704 | 1.56 | 65 | Adjuvant (A) | 2019-03-08 | 2019-03-08 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100403609 |
| 20212862 | 20154705 | 1.81 | 48.1 | null | 2020-04-05 | 2020-04-26 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101260720 |
| 20212868 | 20154706 | 1.58 | 77.6 | Palliative (P) | 2017-11-11 | 2017-11-11 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100754210 |
| 20212876 | 20154708 | 1.71 | 63.6 | Palliative (P) | 2019-11-21 | 2019-12-14 | GEMCITABINE + NAB PACLITAXEL | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 100568381 |
| 20212878 | 20154709 | 1.73 | 91.3 | Neo-adjuvant (N) | 2022-04-09 | 2022-04-18 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100959742 |
| 20212881 | 20154710 | 1.8 | 84.6 | Neo-adjuvant (N) | 2018-10-20 | 2018-11-10 | Capecitabine + Carboplatin + RT | 02 | null | CAPECITABINE + CARBOPLATIN | 100825570 |
| 20212884 | 20154711 | 1.73 | 54 | Palliative (P) | 2018-12-03 | 2018-12-04 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101504953 |
| 20212886 | 20154712 | 1.74 | 90.2 | Palliative (P) | 2019-09-09 | 2019-09-14 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101555059 |
| 20212887 | 20154713 | 1.68 | 59.9 | Palliative (P) | 2020-02-06 | 2020-02-09 | GEMCITABINE + NAB PACLITAXEL | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 101719179 |
| 20212902 | 20154714 | 1.82 | 76.5 | Palliative (P) | 2016-10-15 | 2016-11-08 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100466821 |
| 20212903 | 20154715 | 1.7 | 82.6 | Adjuvant (A) | 2022-03-04 | 2022-03-10 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 101045204 |
| 20212908 | 20154716 | 1.56 | 95.6 | null | 2020-08-01 | 2020-08-26 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 100505501 |
| 20212910 | 20154717 | 1.72 | null | null | 2021-03-10 | 2021-03-12 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100291964 |
| 20212915 | 20154718 | 1.66 | 64.4 | Palliative (P) | 2020-03-22 | 2020-03-24 | HCX | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101339685 |
| 20212918 | 20154719 | 1.69 | 77.9 | Palliative (P) | 2018-12-16 | 2018-12-23 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100242123 |
| 20212920 | 20154720 | 1.76 | 92.6 | Neo-adjuvant (N) | 2019-01-09 | 2019-01-28 | Cape+Cisplatin+Trastuzumab Load | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101227845 |
| 20212921 | 20154721 | 1.75 | 69 | Palliative (P) | 2019-11-19 | 2019-11-26 | GEMCITABINE + NAB PACLITAXEL | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100352897 |
| 20212923 | 20154722 | 1.8 | 57 | Palliative (P) | 2016-05-23 | 2016-07-30 | GEMCITABINE + NAB PACLITAXEL | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 100919768 |
| 20212925 | 20154723 | 1.7 | 104 | Adjuvant (A) | 2022-05-21 | 2022-05-22 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | null | N | GEMCITABINE + NAB-PACLITAXEL | 101259440 |